Cue Biopharma, Inc.CUENASDAQ
Loading
Debt to Equity Over TimeNormalizing
Percentile Rank60
3Y CAGR-18.6%
5Y CAGR+11.9%
Year-over-Year Change
Debt-to-equity ratio
3Y CAGR
-18.6%/yr
Annual compound
5Y CAGR
+11.9%/yr
Recent deceleration
Percentile
P60
Within normal range
vs 5Y Ago
1.8x
Solid growth
Streak
1 yr
Consecutive declineNormalizing
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.16 | -68.7% |
| 2024 | 0.51 | +28.0% |
| 2023 | 0.40 | +34.7% |
| 2022 | 0.29 | +60.2% |
| 2021 | 0.18 | +102.7% |
| 2020 | 0.09 | -14.7% |
| 2019 | 0.11 | - |
| 2018 | 0.00 | -100.0% |
| 2017 | 0.04 | - |
| 2016 | 0.00 | - |